{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:33:31Z","timestamp":1790984011069,"version":"4.1.0"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>What is the role of the hypothalamic neuropeptide neurokinin B (NKB) and its interaction with kisspeptin on GnRH\/LH secretion in women with polycystic ovary syndrome (PCOS)?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>Administration of neurokinin 3 receptor antagonist (NK3Ra) for 7 days reduced LH and FSH secretion and LH pulse frequency in women with PCOS, whilst the stimulatory LH response to kisspeptin-10 was maintained.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>PCOS is characterized by abnormal GnRH\/LH secretion. NKB and kisspeptin are master regulators of GnRH\/LH secretion, but their role in PCOS is unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>The NK3Ra MLE4901, 40\u2009mg orally twice a day, was administered to women with PCOS for 7 days (n\u2009=\u20098) (vs no treatment, n\u2009=\u20097). On the last day of NK3Ra administration or the equivalent day in those not treated, women were randomized to 7-h kisspeptin-10 (4\u2009\u00b5g\/kg\/h i.v.) or vehicle infusion. This was repeated with the alternate infusion in a subsequent cycle.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>Subjects were women with PCOS, studied in a Clinical Research Facility. Reproductive hormones were measured before and after NK3Ra administration. On the last day of NK3Ra administration (or the equivalent cycle day in untreated women), all women attended for an 8-h frequent blood sampling to allow analysis of the pulsatile LH secretion.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>NK3Ra reduced LH secretion (4.0\u2009\u00b1\u20090.4 vs 6.5\u2009\u00b1\u20090.8 IU\/l, P\u2009&amp;lt;\u20090.05) and pulse frequency (0.5\u2009\u00b1\u20090.1 vs 0.8\u2009\u00b1\u20090.1 pulses\/h, P\u2009&amp;lt;\u20090.05); FSH secretion was also reduced (2.0\u2009\u00b1\u20090.3 vs 2.5\u2009\u00b1\u20090.4 IU\/l, P\u2009&amp;lt;\u20090.05). Without NK3Ra pre-treatment, kisspeptin-10 increased LH secretion (5.2\u2009\u00b1\u20090.5 to 7.8\u2009\u00b1\u20091.0 IU\/L, P\u2009&amp;lt;\u20090.05), with a positive relationship to oestradiol concentrations (r2 = 0.59, P\u2009&amp;lt;\u20090.05). After NK3Ra administration, the LH response to kisspeptin-10 was preserved (vehicle 3.5\u2009\u00b1\u20090.3 vs 9.0\u2009\u00b1\u20092.2 IU\/l with kisspeptin-10, P\u2009&amp;lt;\u20090.05), but the positive correlation with oestradiol concentrations was abolished (r2 = 0.07, ns. after NK3Ra). FSH secretion was increased by kisspeptin-10 after NK3Ra treatment, but not without NK3Ra treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>The study did not explore the dose relationship of the effect of NK3R antagonism. The impact of obesity or other aspects of the variability of the PCOS phenotype was not studied due to the small number of subjects.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>These data demonstrate the interactive regulation of GnRH\/LH secretion by NKB and kisspeptin in PCOS, and that the NKB system mediates aspects of oestrogenic feedback.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>Wellcome Trust through Scottish Translational Medicine and Therapeutics Initiative (102419\/Z\/13\/A) and MRC grants (G0701682 to R.P.M. and R.A.A.) and MR\/N022556\/1 to the MRC Centre for Reproductive Health. This work was performed within the Edinburgh Clinical Research Facility. J.T.G. has undertaken consultancy work for AstraZeneca and Takeda Pharmaceuticals and is an employee of Boehringer Ingelheim. R.P.M. has consulted for Ogeda and was CEO of Peptocrine. R.A.A. has undertaken consultancy work for Merck, Ferring, NeRRe Therapeutics and Sojournix Inc. J.D.V. and K.S. have nothing to disclose.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>N\/A.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/deaa104","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T19:11:25Z","timestamp":1590693085000},"page":"1421-1431","source":"Crossref","is-referenced-by-count":58,"title":["Kisspeptin and neurokinin B interactions in modulating gonadotropin secretion in women with polycystic ovary syndrome"],"prefix":"10.1093","volume":"35","author":[{"given":"Karolina","family":"Skorupskaite","sequence":"first","affiliation":[{"name":"MRC Centre for Reproductive Health, The Queen\u2019s Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyothis T","family":"George","sequence":"first","affiliation":[{"name":"Warwick Medical School, Coventry CV4 7AL, UK"},{"name":"Boehringer Ingelheim, Bracknell RG12 8YS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes D","family":"Veldhuis","sequence":"first","affiliation":[{"name":"Endocrine Research Unit, Center for Translational Science Activities, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P","family":"Millar","sequence":"first","affiliation":[{"name":"Centre for Neuroendocrinology and Mammal Research Institute, University of Pretoria, 0028 Pretoria, South Africa"},{"name":"Institute for Infectious Diseases and Molecular Medicine, University of Cape Town, 7925 Observatory, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Anderson","sequence":"first","affiliation":[{"name":"MRC Centre for Reproductive Health, The Queen\u2019s Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"key":"2020062517040911800_deaa104-B1","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1210\/jc.2015-2332","article-title":"Efficacy of Kisspeptin-54 to trigger oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) therapy","volume":"100","author":"Abbara","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2020062517040911800_deaa104-B2","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1210\/en.2010-0174","article-title":"Neurokinin B acts via the neurokinin-3 receptor in the retrochiasmatic area to stimulate luteinizing hormone secretion in sheep","volume":"151","author":"Billings","year":"2010","journal-title":"Endocrinology"},{"key":"2020062517040911800_deaa104-B3","doi-asserted-by":"crossref","first-page":"E3334","DOI":"10.1073\/pnas.1616467114","article-title":"Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome","volume":"114","author":"Caldwell","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020062517040911800_deaa104-B4","doi-asserted-by":"crossref","first-page":"E1458","DOI":"10.1210\/jc.2012-1282","article-title":"Kisspeptin administration to women: a window into endogenous kisspeptin secretion and GnRH responsiveness across the menstrual cycle","volume":"97","author":"Chan","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020062517040911800_deaa104-B5","doi-asserted-by":"crossref","first-page":"10055","DOI":"10.1038\/ncomms10055","article-title":"Novel role for anti-Mullerian hormone in the regulation of GnRH neuron excitability and hormone secretion","volume":"7","author":"Cimino","year":"2016","journal-title":"Nat Commun"},{"key":"2020062517040911800_deaa104-B6","doi-asserted-by":"crossref","first-page":"E10216","DOI":"10.1073\/pnas.1713897114","article-title":"Definition of the hypothalamic GnRH pulse generator in mice","volume":"114","author":"Clarkson","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020062517040911800_deaa104-B7","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1210\/en.2006-0787","article-title":"Postnatal development of kisspeptin neurons in mouse hypothalamus; sexual dimorphism and projections to gonadotropin-releasing hormone neurons","volume":"147","author":"Clarkson","year":"2006","journal-title":"Endocrinology"},{"key":"2020062517040911800_deaa104-B8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2826.2009.01951.x","article-title":"The effects of neurokinin B upon gonadotrophin release in male rodents","volume":"22","author":"Corander","year":"2010","journal-title":"J Neuroendocrinol"},{"key":"2020062517040911800_deaa104-B9","doi-asserted-by":"crossref","first-page":"10972","DOI":"10.1073\/pnas.1834399100","article-title":"Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54","volume":"100","author":"de Roux","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020062517040911800_deaa104-B10","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1210\/jc.2007-1116","article-title":"Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women","volume":"92","author":"Dhillo","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020062517040911800_deaa104-B11","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/en.2015-1409","article-title":"The NK3 receptor antagonist ESN364 interrupts pulsatile LH secretion and moderates levels of ovarian hormones throughout the menstrual cycle","volume":"156","author":"Fraser","year":"2015","journal-title":"Endocrinology"},{"key":"2020062517040911800_deaa104-B12","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1210\/en.2011-1260","article-title":"Kisspeptin signaling is indispensable for neurokinin B, but not glutamate, stimulation of gonadotropin secretion in mice","volume":"153","author":"Garcia-Galiano","year":"2012","journal-title":"Endocrinology"},{"key":"2020062517040911800_deaa104-B13","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1093\/humrep\/des326","article-title":"Kisspeptin-10 stimulation of gonadotrophin secretion in women is modulated by sex steroid feedback","volume":"27","author":"George","year":"2012","journal-title":"Hum Reprod"},{"key":"2020062517040911800_deaa104-B14","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1210\/jc.2016-1202","article-title":"Neurokinin B receptor antagonism in women with polycystic ovary syndrome: a randomized, placebo-controlled trial","volume":"101","author":"George","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2020062517040911800_deaa104-B15","doi-asserted-by":"crossref","first-page":"E1228","DOI":"10.1210\/jc.2011-0089","article-title":"Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men","volume":"96","author":"George","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2020062517040911800_deaa104-B16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"2020062517040911800_deaa104-B17","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1210\/en.2007-0961","article-title":"Kisspeptin neurons in the arcuate nucleus of the ewe express both dynorphin A and neurokinin B","volume":"148","author":"Goodman","year":"2007","journal-title":"Endocrinology"},{"key":"2020062517040911800_deaa104-B18","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1038\/ncomms8502","article-title":"Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations","volume":"6","author":"Hayes","year":"2015","journal-title":"Nat Commun"},{"key":"2020062517040911800_deaa104-B19","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1111\/j.1460-9568.2010.07239.x","article-title":"The kisspeptin system of the human hypothalamus: sexual dimorphism and relationship with gonadotropin-releasing hormone and neurokinin B neurons","volume":"31","author":"Hrabovszky","year":"2010","journal-title":"Eur J Neurosci"},{"key":"2020062517040911800_deaa104-B20","doi-asserted-by":"crossref","first-page":"E1963","DOI":"10.1210\/jc.2011-1408","article-title":"The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans","volume":"96","author":"Jayasena","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2020062517040911800_deaa104-B21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000377702","article-title":"Evidence that neurokinin B controls basal gonadotropin-releasing hormone secretion but is not critical for estrogen-positive feedback in sheep","volume":"101","author":"Li","year":"2015","journal-title":"Neuroendocrinology"},{"key":"2020062517040911800_deaa104-B22","doi-asserted-by":"crossref","first-page":"E538","DOI":"10.1152\/ajpendo.00071.2009","article-title":"Sensitivity and specificity of pulse detection using a new deconvolution method","volume":"297","author":"Liu","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020062517040911800_deaa104-B23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0303-7207(01)00611-6","article-title":"Hypothalamic dysfunction","volume":"183","author":"Marshall","year":"2001","journal-title":"Mol Cell Endocrinol"},{"key":"2020062517040911800_deaa104-B24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jsbmb.2015.10.002","article-title":"The neuroendocrine genesis of polycystic ovary syndrome: a role for arcuate nucleus GABA neurons","volume":"160","author":"Moore","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020062517040911800_deaa104-B25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yfrne.2017.05.002","article-title":"Polycystic ovary syndrome: Understanding the role of the brain","volume":"46","author":"Moore","year":"2017","journal-title":"Front Neuroendocrinol"},{"key":"2020062517040911800_deaa104-B26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/cen.12977","article-title":"Subcutaneous infusion of kisspeptin-54 stimulates gonadotrophin release in women and the response correlates with basal oestradiol levels","volume":"84","author":"Narayanaswamy","year":"2016","journal-title":"Clin Endocrinol (Oxf"},{"key":"2020062517040911800_deaa104-B27","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1210\/jc.2016-1911","article-title":"Investigating the KNDy hypothesis in humans by coadministration of kisspeptin, neurokinin B, and naltrexone in men","volume":"101","author":"Narayanaswamy","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2020062517040911800_deaa104-B28","doi-asserted-by":"crossref","first-page":"E202","DOI":"10.1152\/ajpendo.00517.2010","article-title":"Interactions between kisspeptin and neurokinin B in the control of GnRH secretion in the female rat","volume":"300","author":"Navarro","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020062517040911800_deaa104-B29","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1152\/physrev.00037.2010","article-title":"Kisspeptins and reproduction: physiological roles and regulatory mechanisms","volume":"92","author":"Pinilla","year":"2012","journal-title":"Physiol Rev"},{"key":"2020062517040911800_deaa104-B30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000329045","article-title":"Evidence from the agonadal juvenile male rhesus monkey (Macaca mulatta) for the view that the action of neurokinin B to trigger gonadotropin-releasing hormone release is upstream from the kisspeptin receptor","volume":"94","author":"Ramaswamy","year":"2011","journal-title":"Neuroendocrinology"},{"key":"2020062517040911800_deaa104-B31","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1172\/JCI108400","article-title":"Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome","volume":"57","author":"Rebar","year":"1976","journal-title":"J Clin Invest"},{"key":"2020062517040911800_deaa104-B32","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/humrep\/dez205","article-title":"Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome","volume":"34","author":"Romero-Ruiz","year":"2019","journal-title":"Hum Reprod"},{"key":"2020062517040911800_deaa104-B33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"2020062517040911800_deaa104-B34","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1172\/JCI107454","article-title":"Episodic luteinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanisms","volume":"52","author":"Santen","year":"1973","journal-title":"J Clin Invest"},{"key":"2020062517040911800_deaa104-B35","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1056\/NEJMoa035322","article-title":"The GPR54 gene as a regulator of puberty","volume":"349","author":"Seminara","year":"2003","journal-title":"N Engl J Med"},{"key":"2020062517040911800_deaa104-B36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S37559","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome","volume":"6","author":"Sirmans","year":"2013","journal-title":"Clin Epidemiol"},{"key":"2020062517040911800_deaa104-B37","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/humupd\/dmu009","article-title":"The kisspeptin-GnRH pathway in human reproductive health and disease","volume":"20","author":"Skorupskaite","year":"2014","journal-title":"Hum Reprod Update"},{"key":"2020062517040911800_deaa104-B38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1210\/jc.2017-01306","article-title":"Neurokinin B regulates gonadotropin secretion, ovarian follicle growth, and the timing of ovulation in healthy women","volume":"103","author":"Skorupskaite","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2020062517040911800_deaa104-B39","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1210\/jc.2016-2132","article-title":"Interactions between neurokinin B and kisspeptin in mediating estrogen feedback in healthy women","volume":"101","author":"Skorupskaite","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2020062517040911800_deaa104-B40","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/cen.13445","article-title":"Neurokinin 3 receptor antagonism decreases gonadotropin and testosterone secretion in healthy men","volume":"87","author":"Skorupskaite","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020062517040911800_deaa104-B41","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000473893","article-title":"Neurokinin 3 receptor antagonism reveals roles for neurokinin B in the regulation of gonadotropin secretion and hot flashes in postmenopausal women","volume":"106","author":"Skorupskaite","year":"2018","journal-title":"Neuroendocrinology"},{"key":"2020062517040911800_deaa104-B42","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"2020062517040911800_deaa104-B43","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa073443","article-title":"A GPR54-activating mutation in a patient with central precocious puberty","volume":"358","author":"Teles","year":"2008","journal-title":"N Engl J Med"},{"key":"2020062517040911800_deaa104-B44","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ng.306","article-title":"TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction","volume":"41","author":"Topaloglu","year":"2009","journal-title":"Nat Genet"},{"key":"2020062517040911800_deaa104-B45","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa1111184","article-title":"Inactivating KISS1 mutation and hypogonadotropic hypogonadism","volume":"366","author":"Topaloglu","year":"2012","journal-title":"N Engl J Med"},{"key":"2020062517040911800_deaa104-B46","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1210\/er.2008-0005","article-title":"Motivations and methods for analyzing pulsatile hormone secretion","volume":"29","author":"Veldhuis","year":"2008","journal-title":"Endocr Rev"},{"key":"2020062517040911800_deaa104-B47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000336376","article-title":"Kisspeptin restores pulsatile LH secretion in patients with neurokinin B signaling deficiencies: physiological, pathophysiological and therapeutic implications","volume":"97","author":"Young","year":"2013","journal-title":"Neuroendocrinology"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/6\/1421\/33428937\/deaa104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/6\/1421\/33428937\/deaa104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T21:05:16Z","timestamp":1593119116000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/35\/6\/1421\/5854484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,8]]},"published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deaa104","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6]]},"published":{"date-parts":[[2020,6,1]]}}}